Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combretastatin A4 Phosphate in Neovascular AMD
NCT01570790Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosbretabulin in neovascular age-related macular degeneration (NVAMD), sponsored by Johns Hopkins University. Started May 2003; status: completed.
02
Drugs
fosbretabulin
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT01570790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01570790.